These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7401109)

  • 21. Lactam-conformationally restricted analogs of N alpha-arylsulfonyl arginine amide: design, synthesis and inhibitory activity toward thrombin and related enzymes.
    Okayama T; Seki S; Ito H; Takeshima T; Hagiwara M; Morikawa T
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1683-91. PubMed ID: 8536341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and mechanism of catalysis by proteolytic enzymes. A comparison of the kinetics of hydrolysis of synthetic substrates by bovine alpha- and beta-trypsin.
    Roberts DV; Elmore DT
    Biochem J; 1974 Aug; 141(2):545-54. PubMed ID: 4477005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of methyl esters of arginine-containing oligopeptides on thrombin and trypsin].
    Poiarkova SA; Kibirev VK; Serebrianyĭ SB
    Ukr Biokhim Zh (1978); 1987; 59(5):5-11. PubMed ID: 3686693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of L- and D-arginine and some related esters on the cytosolic mechanisms of alpha-thrombin-induced human platelet activation.
    Failli P; Cecchi E; Ruocco C; Fazzini A; Giotti A
    Br J Pharmacol; 1993 Sep; 110(1):213-8. PubMed ID: 8220881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presteady state kinetics of trypsin-catalyzed hydrolyses of dansyl-arginine derivatives.
    Goto S; Hess GP
    J Biochem; 1979 Sep; 86(3):619-25. PubMed ID: 41834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p-Nitrobenzyl p-toluenesulfonyl-L-arginine: a chromogenic substrate for thrombin, plasmin and trypsin.
    Plaut GW
    Haemostasis; 1978; 7(2-3):105-8. PubMed ID: 26627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential specificities of the thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors.
    Weinstein MJ; Doolittle RF
    Biochim Biophys Acta; 1972 Feb; 258(2):577-90. PubMed ID: 4258697
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
    Roberts PS; Hughes HN; Fleming PB
    Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinetics of hydrolysis of some extended N-aminoacyl-l-lysine methyl esters.
    Green GD; Tomalin G
    Eur J Biochem; 1976 Sep; 68(1):131-7. PubMed ID: 986943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of salts and of ionic strength on the hydrolysis of TAME (p-toluenesulfonyl-L-arginine methyl ester) by thrombin and thrombokinase.
    Roberts PS; Fleming PB
    Thromb Diath Haemorrh; 1972 Jul; 27(3):573-83. PubMed ID: 4676964
    [No Abstract]   [Full Text] [Related]  

  • 31. Steady-state kinetics of trypsin-catalyzed hydrolysis of a synthetic substrate, dansyl-D-arginine methyl ester.
    Goto S
    J Biochem; 1980 Feb; 87(2):399-406. PubMed ID: 7358645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and evaluation of graftable thrombin inhibitors for the preparation of blood-compatible polymer materials.
    Salvagnini C; Michaux C; Remiche J; Wouters J; Charlier P; Marchand-Brynaert J
    Org Biomol Chem; 2005 Dec; 3(23):4209-20. PubMed ID: 16294249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antithrombin activity of methyl esters of arginine-containing peptides].
    Kostiuchenko NV; Romanova VP; Serebrianyĭ SB; Kibirev VK
    Ukr Biokhim Zh (1978); 1987; 59(3):8-12. PubMed ID: 3603738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity enhancement induced by substitution of non-natural analogues of arginine and lysine in arginine-based thrombin inhibitors.
    Kokko KP; Arrigoni CE; Dix TA
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1947-50. PubMed ID: 11459667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartame and aspartame derivatives effect human thrombin catalytic activity.
    Scheffler JE; Berliner LJ
    Biophys Chem; 2004 Dec; 112(2-3):285-91. PubMed ID: 15572260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N alpha-dansyl-L-arginine 4-phenylpiperidine amide. A potent and selective inhibitor of horse serum cholinesterase.
    Hijikata-Okunomiya A; Okamoto S; Tamao Y; Kikumoto R
    J Biol Chem; 1988 Aug; 263(23):11269-73. PubMed ID: 3403526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the catalytic properties of thrombin and trypsin by kinetic analysis on the basis of active enzyme concentration.
    Takasaki SI; Kasai KI; Ishii SI
    J Biochem; 1975 Dec; 78(6):1275-85. PubMed ID: 1241585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of biguanides on thrombokinase, thrombin and trypsin.
    Roberts PS; Fleming PB
    Thromb Diath Haemorrh; 1975 Sep; 34(1):246-55. PubMed ID: 242090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the association between prothrombin fragment 2 and alpha-thrombin.
    Myrmel KH; Lundblad RL; Mann KG
    Biochemistry; 1976 Apr; 15(8):1767-73. PubMed ID: 944591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.